Insuman Comb 50/50: combined insulin for the treatment of diabetes mellitus
Insuman Comb 50/50 is a combination insulin that is used to treat diabetes mellitus in adults. It contains two types of insulin: short-acting (or fast-acting) insulin and intermediate-acting insulin. This insulin helps control blood glucose levels by regulating levels after meals and between meals.
The country of origin of Insuman Comb 50/50 is Germany. This insulin belongs to the pharmaceutical group of insulins with a combined duration of action and is produced by Hoechst AG in Germany. The international name of this insulin is Insulin-Comb, and it also has several synonyms, such as Actrafan HM penfil 100, Berlinsulin N 10/90 U-40, Berlinsulin N 10/90 pen, Berlinsulin N 20/80 U-40, Berlinsulin N 20/80 pen, Berlinsulin N 30/70 U-40, Berlinsulin N 30/70 pen, Berlinsulin N 40/60 U-40, Berlinsulin N 40/60 pen, Biogulin 30/70 U-100, Insul.
Insuman Comb 50/50 is available in two dosage forms: injection suspension 40 IU/ml and injection suspension 100 IU/ml. This insulin is usually injected subcutaneously into the thigh, abdomen, or upper arm.
As a rule, the dosage of Insuman Comb 50/50 insulin depends on the individual needs of each patient and may vary depending on blood glucose levels, diet, physical activity and other factors. Therefore, it is important to monitor your blood glucose levels and follow your doctor's recommendations for using this insulin.
Insuman Comb 50/50 is an effective insulin for controlling diabetes mellitus in adults. However, like any other drug, it has side effects and contraindications, so before starting use, you must consult your doctor and strictly follow his recommendations.